New hope for cancer patients in Scotland with the launch of a clinical trial for a form of the disease linked to asbestos exposure, a charity has announced.
Each year, the area accounts for about half of all cases of the disease in Scotland, according to Public Health Scotland figures. “We are also hoping to develop similar trials involving direct treatment into the pleural space through our Cancer Research UK-funded network.” RS Oncology CEO Jarrett Duncan said: “RSO-021 is an exciting, novel, anti-cancer treatment that can potentially help a global population of cancer patients who are left with little to no options.
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more: